Paper499332
Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
Herlyn D and 3 others. Eur J Immunol, 1979. Cited by 159 papers, by iCite.
Cite this record
ConductScience Library. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Papers, record 499332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/499332
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neoplasm | Major topic |
| Antibody-Dependent Cell Cytotoxicity | Major topic |
| Colonic Neoplasms | Major topic |
| Melanoma | Major topic |
| Rectal Neoplasms | Major topic |
| Animals | |
| Cell Line | |
| Clone Cells | |
| Cytotoxicity, Immunologic | |
| Humans | |
| Mice | |
| Mice, Nude |
Source PubMed
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40242505 | Nanotherapeutic strategies exploiting biological traits of cancer stem cells. | Bioact Mater | 2025 | https://conductscience.org/library/papers/40242505 | PubMed |
| 38791091 | Regulation of the Function and Expression of EpCAM. | Biomedicines | 2024 | https://conductscience.org/library/papers/38791091 | PubMed |
| 38612911 | Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612911 | PubMed |
| 36238297 | Recent advances in CAR-T cells therapy for colorectal cancer. | Front Immunol | 2022 | https://conductscience.org/library/papers/36238297 | PubMed |
| 35891197 | NK Cell-Based Immunotherapy in Colorectal Cancer. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35891197 | PubMed |
| 34790117 | Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34790117 | PubMed |
| 34209658 | Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition. | Biomolecules | 2021 | https://conductscience.org/library/papers/34209658 | PubMed |
| 32486423 | Current View on EpCAM Structural Biology. | Cells | 2020 | https://conductscience.org/library/papers/32486423 | PubMed |
| 30185875 | EpCAM homo-oligomerization is not the basis for its role in cell-cell adhesion. | Sci Rep | 2018 | https://conductscience.org/library/papers/30185875 | PubMed |
| 28393933 | EpCAM Intracellular Domain Promotes Porcine Cell Reprogramming by Upregulation of Pluripotent Gene Expression via Beta-catenin Signaling. | Sci Rep | 2017 | https://conductscience.org/library/papers/28393933 | PubMed |
| 26292218 | Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM). | J Biol Chem | 2015 | https://conductscience.org/library/papers/26292218 | PubMed |
| 26116735 | Antibodies: At The Nexus of Antigens and Cancer Vaccines. | J Infect Dis | 2015 | https://conductscience.org/library/papers/26116735 | PubMed |
| 24937249 | Remembrances of Hilary Koprowski from a Surgeon's Perspective. | Monoclon Antib Immunodiagn Immunother | 2014 | https://conductscience.org/library/papers/24937249 | PubMed |
| 24906438 | The overexpression of epithelial cell adhesion molecule (EpCAM) in glioma. | J Neurooncol | 2014 | https://conductscience.org/library/papers/24906438 | PubMed |
| 22647938 | EpCAM and its potential role in tumor-initiating cells. | Cell Adh Migr | 2012 | https://conductscience.org/library/papers/22647938 | PubMed |
| 21196254 | Colon cancer stem cells: implications in carcinogenesis. | Front Biosci (Landmark Ed) | 2011 | https://conductscience.org/library/papers/21196254 | PubMed |
| 18508155 | Use of antibodies and immunoconjugates for the therapy of more accessible cancers. | Adv Drug Deliv Rev | 2008 | https://conductscience.org/library/papers/18508155 | PubMed |
| 17622246 | Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17622246 | PubMed |
| 10965023 | Antibody-dependent cytotoxicity mediated by chimeric monoclonal antibody Nd2 and experimental immunotherapy for pancreatic cancer. | Jpn J Cancer Res | 2000 | https://conductscience.org/library/papers/10965023 | PubMed |
| 10852962 | Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10852962 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/499332
GET https://conductscience.org/api/papers/v1/499332/cited_by?page=2